RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+9.33%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$5.05B
AUM Growth
+$5.05B
(+10%)
Cap. Flow
+$474M
Cap. Flow
% of AUM
9.39%
Top 10 Holdings %
Top 10 Hldgs %
27.44%
Holding
165
New
13
Increased
67
Reduced
10
Closed
9
Top Buys
| 1 |
Agilon Health
AGL
|
$284M |
| 2 |
LENZ
LENZ Therapeutics
LENZ
|
$66.1M |
| 3 |
VERV
Verve Therapeutics
VERV
|
$58M |
| 4 |
Lifestance Health
LFST
|
$41.8M |
| 5 |
NeueHealth
NEUE
|
$40.8M |
Top Sells
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$100M |
| 2 |
AstraZeneca
AZN
|
$32.3M |
| 3 |
Inspire Medical Systems
INSP
|
$20.7M |
| 4 |
Atea Pharmaceuticals
AVIR
|
$19.4M |
| 5 |
UnitedHealth
UNH
|
$14M |
Sector Composition
| 1 | Healthcare | 94.39% |
| 2 | Consumer Staples | 1.63% |
| 3 | Industrials | 0.72% |
| 4 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Boston Scientific
BSX
$156B
| $34.2M | 0.68% | 800,000 | – | – |
|
|
PPD
52
DELISTED
PPD, Inc. Common Stock
PPD
| $31.1M | 0.61% | 675,000 | – | – |
|
53
Ascendis Pharma
ASND
$11.8B
| $30.7M | 0.61% | 233,500 | – | – |
|
54
Kymera Therapeutics
KYMR
$2.95B
| $30.4M | 0.6% | 626,527 +4,750 | +0.8% | +$230K |
|
55
iRhythm Technologies
IRTC
$5.46B
| $29.7M | 0.59% | 448,000 +15,504 | +4% | +$1.03M |
|
56
Cullinan Oncology
CGEM
$445M
| $27.7M | 0.55% | 1,075,912 | – | – |
|
57
Adaptive Biotechnologies
ADPT
$2.01B
| $26.6M | 0.52% | 650,000 | – | – |
|
58
Mirum Pharmaceuticals
MIRM
$3.71B
| $26.3M | 0.52% | 1,523,723 +20,923 | +1% | +$362K |
|
59
Pulmonx
LUNG
$69.7M
| $26.1M | 0.52% | 592,500 | – | – |
|
|
ALLK
60
DELISTED
Allakos
ALLK
| $26.1M | 0.52% | 305,706 | – | – |
|
|
CERE
61
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $26.1M | 0.51% | 1,016,945 +11,845 | +1% | +$303K |
|
62
Madrigal Pharmaceuticals
MDGL
$9.76B
| $25.6M | 0.51% | 262,500 +4,000 | +2% | +$390K |
|
63
Sarepta Therapeutics
SRPT
$1.78B
| $25.6M | 0.51% | 328,750 | – | – |
|
64
Bolt Biotherapeutics
BOLT
$9.85M
| $25M | 0.49% | 1,619,248 +60,000 | +4% | +$928K |
|
|
EPZM
65
DELISTED
Epizyme, Inc
EPZM
| $25M | 0.49% | 3,011,487 +208,533 | +7% | +$1.73M |
|
66
Guardant Health
GH
$8.41B
| $24.8M | 0.49% | 200,000 | – | – |
|
67
Acadia Pharmaceuticals
ACAD
$4.38B
| $24.4M | 0.48% | 1,000,000 -76,200 | -7% | -$1.86M |
|
68
CONMED
CNMD
$1.68B
| $22.3M | 0.44% | 162,500 +77,415 | +91% | +$10.6M |
|
|
OSH
69
DELISTED
Oak Street Health, Inc.
OSH
| $22M | 0.43% | 375,000 | – | – |
|
70
Travere Therapeutics
TVTX
$1.56B
| $21.8M | 0.43% | 1,494,164 +18,600 | +1% | +$271K |
|
71
Collegium Pharmaceutical
COLL
$1.22B
| $21.7M | 0.43% | 920,000 | – | – |
|
72
BioMarin Pharmaceuticals
BMRN
$11.2B
| $21.2M | 0.42% | 253,500 | – | – |
|
|
ABCM
73
DELISTED
Abcam plc American Depositary Shares
ABCM
| $20.9M | 0.41% | 1,097,500 +28,264 | +3% | +$538K |
|
|
XENT
74
DELISTED
Intersect ENT, Inc
XENT
| $20.9M | 0.41% | 1,220,000 +139,800 | +13% | +$2.39M |
|
75
Rigel Pharmaceuticals
RIGL
$697M
| $20.6M | 0.41% | 4,754,900 +12,900 | +0.3% | +$56K |
|